Related Experiment Video
Updated: Mar 8, 2026
Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study
Kirsten E Peters1, Wendy A Davis1, Kevin Taddei2
1School of Medicine and Pharmacology, University of Western Australia, Fremantle, WA, Australia.
Individuals with type 2 diabetes exhibit lower plasma amyloid-beta (Aβ) levels, with a higher Aβ42:Aβ40 ratio. These findings are crucial for understanding Alzheimer's disease biomarkers.
Area of Science:
- Neuroscience
- Endocrinology
- Biomarker Research
Background:
- Type 2 diabetes (T2D) is linked to Alzheimer's disease (AD), yet plasma amyloid-beta (Aβ) levels in T2D patients remain understudied.
- Investigating plasma Aβ in T2D is essential for understanding AD pathogenesis and developing diagnostic tools.
Purpose of the Study:
- To compare plasma Aβ40 and Aβ42 concentrations in cognitively normal individuals with and without type 2 diabetes.
- To assess the relationship between type 2 diabetes and plasma Aβ peptide levels.
Main Methods:
- A multiplex immunoassay was used to measure plasma Aβ40 and Aβ42 in 194 T2D patients from the Fremantle Diabetes Study and 194 matched controls from the Australian Imaging, Biomarkers and Lifestyle Study.
- Participants were age-, sex-, and APOEɛ4 allele-matched.
Main Results:
- Plasma Aβ40 and Aβ42 levels were significantly lower in individuals with type 2 diabetes compared to controls (p < 0.001).
- The Aβ42:Aβ40 ratio was significantly higher in the type 2 diabetes group (p < 0.001).
- Lower plasma Aβ40 levels in T2D patients correlated with higher estimated glomerular filtration rates, despite overall lower renal function in the T2D cohort.
Conclusions:
- Type 2 diabetes is associated with altered plasma amyloid-beta peptide concentrations.
- Plasma Aβ levels in T2D patients show significant variation that must be considered when using them as biomarkers for Alzheimer's disease.
More Related Videos
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
10:51Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting
Published on: April 10, 2014
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...